EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Nelarabine-associated rhabdomyolysis with severe creatine kinase elevation in a pediatric patient with T-cell acute lymphoblastic leukemia: a case report

Fulden Aycan, Anna E Spykerman, Christopher Carter Barnett

Frontiers in Oncology · 05.08.2026 · 16

DOI: 10.3389/fonc.2026.1901440 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 05.08.2026. Verfasst von Fulden Aycan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Stead Family Department of Pediatrics, Carver College of Medicine, The University of Iowa, Iowa City, IA, United States. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nelarabine is a purine nucleoside analog used in relapsed or refractory T-cell acute lymphoblastic leukemia (T-ALL) and in up-front pediatric therapy. Although neurologic toxicity is dose-limiting, skeletal muscle toxicity, including rhabdomyolysis, has been reported. Rhabdomyolysis occurred in approximately 2% of nelarabine-treated patients in pediatric COG AALL0434, although the clinical features of these events were not detailed. We report a 7-year-old patient with T-ALL who developed rapidly progressive diffuse myalgia, muscle stiffness, impaired ambulation, dark urine, presumptive myoglobinuria, and a peak creatine kinase (CK) level exceeding 70,000 U/L shortly after nelarabine administration during consolidation. Nelarabine was discontinued, and aggressive intravenous hydration led to complete clinical and biochemical recovery without acute kidney injury or renal replacement therapy. This case provides a detailed pediatric description of clinically overt nelarabine-associated rhabdomyolysis and emphasizes early recognition, renal-protective management, and CK monitoring in symptomatic patients.

Schlagwörter

Stichwörter der Autor:innen

T-ALLT-cell acute lymphoblastic leukemiachemotherapy toxicitynelarabinepediatricrhabdomyolysis

Autor:innen und Institutionen

  • Stead Family Department of Pediatrics, Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.

Zitieren

APA

Aycan, F., Spykerman, A. E., & Barnett, C. C. (2026). Nelarabine-associated rhabdomyolysis with severe creatine kinase elevation in a pediatric patient with T-cell acute lymphoblastic leukemia: a case report. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1901440

Vancouver

Aycan F, Spykerman AE, Barnett CC. Nelarabine-associated rhabdomyolysis with severe creatine kinase elevation in a pediatric patient with T-cell acute lymphoblastic leukemia: a case report. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1901440

BibTeX
@article{Aycan2026,
  author = {Aycan, Fulden and Spykerman, Anna E and Barnett, Christopher Carter},
  title = {Nelarabine-associated rhabdomyolysis with severe creatine kinase elevation in a pediatric patient with T-cell acute lymphoblastic leukemia: a case report},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1901440}
}
Kostenlos starten →